These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z; Kala P Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914 [TBL] [Abstract][Full Text] [Related]
13. Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management. Reny JL; Bonvini RF; Bonvini JM; Roffi M; Fontana P Cardiovasc Ther; 2012 Feb; 30(1):e41-50. PubMed ID: 21073667 [TBL] [Abstract][Full Text] [Related]
14. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]
15. Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel. Martin MT; Spinler SA; Nutescu EA Clin Ther; 2011 Apr; 33(4):425-42. PubMed ID: 21635989 [TBL] [Abstract][Full Text] [Related]
16. Oral antiplatelet therapy for the management of acute coronary syndromes: defining the role of prasugrel. Devabhakthuni S; Seybert AL Crit Care Nurse; 2011 Feb; 31(1):51-63. PubMed ID: 20592188 [TBL] [Abstract][Full Text] [Related]
17. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Reaume KT; Regal RE; Dorsch MP Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394 [TBL] [Abstract][Full Text] [Related]